THERAVANCE BIOPHARMA, INC. ORDINARY SHARE PURCHASE AGREEMENT March 14, 2016Ordinary Share Purchase Agreement • May 10th, 2016 • Theravance Biopharma, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 10th, 2016 Company Industry JurisdictionTHIS ORDINARY SHARE PURCHASE AGREEMENT (the “Agreement”) is made as of the 14th day of March, 2016, by and among Theravance Biopharma, Inc., a Cayman Islands exempted company (the “Company”) and Glaxo Group Limited, a limited liability company organized under the laws of England and Wales (“GSK”).